Global N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) Therapeutics Pipeline Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for N-Formyl Peptide Receptor 2, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for N-Formyl Peptide Receptor 2 and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. N-Formyl Peptide Receptor 2 Overview
  3. Therapeutics Development
  4. Pipeline Products for N-Formyl Peptide Receptor 2 - Overview
  5. Pipeline Products for N-Formyl Peptide Receptor 2 - Comparative Analysis
  6. N-Formyl Peptide Receptor 2 - Therapeutics under Development by Companies
  7. N-Formyl Peptide Receptor 2 - Therapeutics under Investigation by Universities/Institutes
  8. N-Formyl Peptide Receptor 2 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. N-Formyl Peptide Receptor 2 - Products under Development by Companies
  13. N-Formyl Peptide Receptor 2 - Products under Investigation by Universities/Institutes
  14. N-Formyl Peptide Receptor 2 - Companies Involved in Therapeutics Development
  • Bristol-Myers Squibb Company
  • CohBar, Inc.
  • Polyphor Ltd.

For more information visit http://www.researchandmarkets.com/research/hx27v6/nformyl_peptide

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716